Publications by authors named "L G J M Borghans"

Article Synopsis
  • The study investigates the effects of β-adrenoceptor acting drugs on cognitive function in healthy volunteers and Parkinson's disease patients.
  • Clenbuterol showed improvements in cognitive tasks and pupil reactions, while pindolol had negative effects on performance.
  • The findings suggest that clenbuterol might enhance cognitive abilities via stimulation of β2-adrenoceptors in the central nervous system.
View Article and Find Full Text PDF

In many countries, standardized math tests are important for achieving academic success. Here, we examine whether content of items, the story that explains a mathematical question, biases performance of low-SES students. In a large-scale cohort study of Trends in International Mathematics and Science Studies (TIMSS)-including data from 58 countries from students in grades 4 and 8 (N = 5501,165)-we examine whether item content that is more likely related to challenges for low-SES students (money, food, social relationships) improves their performance, compared with their average math performance.

View Article and Find Full Text PDF
Article Synopsis
  • Sensory hypersensitivity (SHS) is a common issue after acquired brain injury (ABI) that negatively impacts both mental and physical health.
  • The study involved 19 adults with ABI who participated in interviews to identify triggers for SHS and how they cope with it, revealing a model that connects sensory environment demands with individual coping resources.
  • This model suggests SHS arises from mismatches in the sensory environment and personal resources, creating a cycle affected by fatigue, and highlights potential coping strategies to improve outcomes for ABI patients.
View Article and Find Full Text PDF

Aims: Dysfunction of nitric oxide-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate signalling is implicated in the pathophysiology of cognitive impairment. Zagociguat is a central nervous system (CNS) penetrant sGC stimulator designed to amplify nitric oxide-cyclic guanosine monophosphate signalling in the CNS. This article describes a phase 1b study evaluating the safety and pharmacodynamic effects of zagociguat.

View Article and Find Full Text PDF

Soluble guanylate cyclase (sGC) and its product, cyclic guanosine monophosphate, play a role in learning and memory formation. Zagociguat (CY6463) is a novel stimulator of sGC being developed for the treatment of neurodegenerative disease. Single zagociguat doses of 0.

View Article and Find Full Text PDF